Tennessee provider seeks to make genomic information easily available
at the point of care

PITTSBURGH & CHICAGO–(BUSINESS WIRE)–Allscripts
Healthcare Solutions, Inc. (NASDAQ: MDRX) announced today that Murfreesboro
Medical Clinic and SurgiCenter (MMC) has selected 2bPrecise
to support its precision medicine strategy, beginning with
pharmacogenomics (PGx) at the point of care.

The only multispecialty, physician-owned clinic in Rutherford County,
TN, MMC became an advocate of genomics and PGx several years ago, with
providers ordering molecular tests for select patients to support
diagnostic and treatment decisions. They found it difficult to apply
genomic insights to medical decisions during patient encounters,
however, because test results were not integrated with clinical
information or easily available within the EHR workflow.

“We’re deeply committed to providing exceptional care to members of our
community,” says Nicholas Cote, D.O., CMIO and President of the Board
for MMC. “We recognize that using science to drive medical treatment is
infinitely more effective than trial and error. The 2bPrecise platform
will help equip our clinicians to identify the best medications for
individual patients, achieving better results faster and with fewer side
effects. Not only is this good medicine, but it greatly enhances the
patient experience as well.”

2bPrecise, a wholly owned Allscripts subsidiary, developed its platform
to serve as the final bridge between the science of genomics and
clinical application. It consumes data from any lab source or knowledge
base and delivers it in an actionable format and vocabulary to the
clinical workflow, regardless of the provider’s EHR.

Dr. Cote notes that use of PGx test results in family practice is
especially beneficial, as it serves as the “epicenter” of care, with
primary care providers supporting the overall management of the patient.
Over time, leadership at MMC anticipates expanding to areas of precision
medicine beyond PGx. The 2bPrecise solution can serve as the foundation
for long-term needs, enabling MMC to help clinicians identify patients
at risk for heritable diseases across specialties, arrive at precise
diagnoses earlier and ultimately select the best treatment based on the
patient’s genetic profile.

Implementation of the platform is underway, with go-live anticipated
later this year. 2bPrecise will be integrated with MMC’s current
clinical systems, including Allscripts TouchWorks® EHR. Relevant PGx
information will be brought to the provider’s attention via the
2bPrecise Genomic EHR Mentor (GEM), an applet that floats on top of the
EHR workflow.

“We’re delighted to partner with Dr. Cote and his team on MMC’s
precision medicine strategy,” says Assaf Halevy, founder and CEO of
2bPrecise. “It’s clear that MMC leadership has a long-term vision to
leverage innovation for the good of the patient, a mission that aligns
closely with 2bPrecise’s corporate values.”

About 2bPrecise

The cloud-based 2bPrecise platform consumes genomic/genetic data (from
any molecular lab) and clinical information (from any EHR), combining
them into a comprehensive patient record. The solution applies insights
from multiple curated, evidence-based knowledgebases and then injects
the data back into the provider’s native workflow. The 2bPrecise
platform creates a discrete information layer that follows the patient
as he or she moves into various clinical settings, so the entire care
team can access valuable insights – preventing information from being
isolated in a single care encounter or specialty area, while enabling
providers to arrive at accurate diagnoses sooner and deliver therapeutic
value faster. Learn more at www.2bPreciseHealth.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and operational
results. Our innovative solutions connect people, places and data across
an Open, Connected Community of Health. Connectivity empowers
caregivers and consumers to make better decisions, delivering better
care for healthier populations. To learn more, visit www.allscripts.com,
Twitter,
YouTube
and It
Takes A Community: The Allscripts Blog.

© 2019 Allscripts Healthcare, LLC and/or its affiliates. All Rights
Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all rights
reserved. Reference to these products is not intended to imply
affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its
affiliates.

Contacts

Investors:
Stephen Shulstein
312-386-6735
[email protected]

Media:
Concetta
Rasiarmos
Allscripts
312-447-2466
[email protected]

Danielle
Johns
Aria Marketing for 2bPrecise
617-332-9999 ext. 241
[email protected]